<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="review-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Malar J</journal-id><journal-title>Malaria Journal</journal-title><issn pub-type="epub">1475-2875</issn><publisher><publisher-name>BioMed Central</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">19032767</article-id><article-id pub-id-type="pmc">2611997</article-id><article-id pub-id-type="publisher-id">1475-2875-7-244</article-id><article-id pub-id-type="doi">10.1186/1475-2875-7-244</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>The content of African diets is adequate to achieve optimal efficacy with fixed-dose artemether-lumefantrine: a review of the evidence</article-title></title-group><contrib-group><contrib id="A1" corresp="yes" contrib-type="author"><name><surname>Premji</surname><given-names>Zulfiqarali G</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>zpremji@muchs.ac.tz</email></contrib><contrib id="A2" contrib-type="author"><name><surname>Abdulla</surname><given-names>Salim</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>salim.abdulla@gmail.com</email></contrib><contrib id="A3" contrib-type="author"><name><surname>Ogutu</surname><given-names>Bernhards</given-names></name><xref ref-type="aff" rid="I3">3</xref><email>bogutu@wrp-ksm.org</email></contrib><contrib id="A4" contrib-type="author"><name><surname>Ndong</surname><given-names>Alice</given-names></name><xref ref-type="aff" rid="I4">4</xref><email>andong@cenerkenya.org</email></contrib><contrib id="A5" contrib-type="author"><name><surname>Falade</surname><given-names>Catherine O</given-names></name><xref ref-type="aff" rid="I5">5</xref><email>fallady@skannet.com</email></contrib><contrib id="A6" contrib-type="author"><name><surname>Sagara</surname><given-names>Issaka</given-names></name><xref ref-type="aff" rid="I6">6</xref><email>isagara@mrtcbko.org</email></contrib><contrib id="A7" contrib-type="author"><name><surname>Mulure</surname><given-names>Nathan</given-names></name><xref ref-type="aff" rid="I7">7</xref><email>nathan.mulure@novartis.com</email></contrib><contrib id="A8" contrib-type="author"><name><surname>Nwaiwu</surname><given-names>Obiyo</given-names></name><xref ref-type="aff" rid="I8">8</xref><email>obiyo.nwaiwu@novartis.com</email></contrib><contrib id="A9" contrib-type="author"><name><surname>Kokwaro</surname><given-names>Gilbert</given-names></name><xref ref-type="aff" rid="I9">9</xref><xref ref-type="aff" rid="I10">10</xref><email>GKokwaro@nairobi.kemri-wellcome.org</email></contrib></contrib-group><aff id="I1"><label>1</label>Department of Parasitology/Medical Entomology, School of Public Health and Social Sciences, Muhimbili University College of Health Sciences, Box 65011, Dar-es-Salaam, Tanzania</aff><aff id="I2"><label>2</label>Ifakara Health Research and Development Centre, Dar-es-Salaam, Tanzania</aff><aff id="I3"><label>3</label>Centre for Clinical Research, Kenya Medical Research Institute, Kisumu, Kenya</aff><aff id="I4"><label>4</label>Centre for Nutrition Education and Research, Nairobi, Kenya</aff><aff id="I5"><label>5</label>Clinical Pharmacology Department, University College Hospital, Ibadan, Nigeria</aff><aff id="I6"><label>6</label>Malaria Research and Training Center, University of Bamako, Bamako, Mali</aff><aff id="I7"><label>7</label>Novartis Pharma AG, Nairobi, Kenya</aff><aff id="I8"><label>8</label>Novartis Pharma AG, Lagos, Nigeria</aff><aff id="I9"><label>9</label>Kenya Medical Research Institute (KEMRI)/Wellcome Trust Programme, Nairobi</aff><aff id="I10"><label>10</label>Department of Pharmaceutics and Pharmacy Practice, College of Health Science, University of Nairobi, Kenya</aff><pub-date pub-type="collection"><year>2008</year></pub-date><pub-date pub-type="epub"><day>25</day><month>11</month><year>2008</year></pub-date><volume>7</volume><fpage>244</fpage><lpage>244</lpage><ext-link ext-link-type="uri" xlink:href="http://www.malariajournal.com/content/7/1/244"/><history><date date-type="received"><day>2</day><month>9</month><year>2008</year></date><date date-type="accepted"><day>25</day><month>11</month><year>2008</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2008 Premji et al; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2008</copyright-year><copyright-holder>Premji et al; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0"/>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p><!--<rdf xmlns="http://web.resource.org/cc/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1" xmlns:dcterms="http://purl.org/dc/terms"><Work xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" rdf:about=""><license rdf:resource="http://creativecommons.org/licenses/by/2.0"/><dc:type rdf:resource="http://purl.org/dc/dcmitype/Text"/><dc:author>
               Premji
               G
               Zulfiqarali
               
               zpremji@muchs.ac.tz
            </dc:author><dc:title>
            The content of African diets is adequate to achieve optimal efficacy with fixed-dose artemether-lumefantrine: a review of the evidence
         </dc:title><dc:date>2008</dc:date><dcterms:bibliographicCitation>Malaria Journal 7(1): 244-. (2008)</dcterms:bibliographicCitation><dc:identifier type="sici">1475-2875(2008)7:1&#x0003c;244&#x0003e;</dc:identifier><dcterms:isPartOf>urn:ISSN:1475-2875</dcterms:isPartOf><License rdf:about="http://creativecommons.org/licenses/by/2.0"><permits rdf:resource="http://web.resource.org/cc/Reproduction" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/Distribution" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Notice" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Attribution" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/DerivativeWorks" xmlns=""/></License></Work></rdf>--></license></permissions><abstract><p>A fixed-dose combination of artemether-lumefantrine (AL, Coartem<sup>&#x000ae;</sup>) has shown high efficacy, good tolerability and cost-effectiveness in adults and children with uncomplicated malaria caused by <italic>Plasmodium falciparum</italic>. Lumefantrine bioavailability is enhanced by food, particularly fat.</p><p>As the fat content of sub-Saharan African meals is approximately a third that of Western countries, it raises the question of whether fat consumption by African patients is sufficient for good efficacy. Data from healthy volunteers have indicated that drinking 36 mL soya milk (containing only 1.2 g of fat) results in 90% of the lumefantrine absorption obtained with 500 mL milk (16 g fat). African diets are typically based on a carbohydrate staple (starchy root vegetables, fruit [plantain] or cereals) supplemented by soups, relishes and sauces derived from vegetables, pulses, nuts or fish. The most important sources of dietary fat in African countries are oil crops (e.g. peanuts, soya beans) and cooking oils as red palm, peanut, coconut and sesame oils. Total fat intake in the majority of subSaharan countries is estimated to be in the range 30&#x02013;60 g/person/day across the whole population (average 43 g/person/day). Breast-feeding of infants up to two years of age is standard, with one study estimating a fat intake of 15&#x02013;30 g fat/day from breast milk up to the age of 18 months. Weaning foods typically contain low levels of fat, and the transition from breast milk to complete weaning is associated with a marked reduction in dietary fat. Nevertheless, fat intake &#x0003e;10 g/day has been reported in young children post-weaning. A randomized trial in Uganda reported no difference in the efficacy of AL between patients receiving supervised meals with a fixed fat content (~23 g fat) or taking AL unsupervised, suggesting that fat intake at home was sufficient for optimal efficacy. Moreover, randomized trials in African children aged 5&#x02013;59 months have shown similar high cure rates to those observed in older populations, indicating that food consumption is adequate post-weaning. In conclusion, it appears that only a very small amount of dietary fat is necessary to ensure optimal efficacy with AL and that the fat content of standard meals or breast milk in sub-Saharan Africa is adequate.</p></abstract></article-meta></front><body><sec><title>Background</title><p>Progress in the ontrol and treatment of malaria in Africa has been threatened by growing resistance to previously effective therapies, notably chloroquine and sulphadoxine/pyrimethamine. Combination therapy is now widely regarded as the most effective strategy for limiting the emergence and spread of resistance and combination treatment based on artemisinin is now recommended by the World Health Organization (WHO) [<xref ref-type="bibr" rid="B1">1</xref>].</p><p>Artemether-lumefantrine (AL, Coartem<sup>&#x000ae;</sup>, Novartis Pharma AG, Basel, Switzerland) combines the artemisinin-derivative artemether, which has a prompt onset of action and provides fast symptomatic relief, with lumefantrine, which has a slower onset of action and clears residual parasites [<xref ref-type="bibr" rid="B2">2</xref>]. AL has consistently shown high efficacy and tolerability in African adults and children with uncomplicated malaria caused by <italic>Plasmodium falciparum</italic>, achieving 28-day polymerase chain reaction (PCR)-corrected parasitological cure rates of &#x0003e;95% [<xref ref-type="bibr" rid="B3">3</xref>-<xref ref-type="bibr" rid="B7">7</xref>]. AL is the first and only fixed-dose artemisinin-based combination treatment (ACT) pre-qualified by the WHO, and has now been adopted as first-line treatment for uncomplicated malaria due to <italic>P falciparum </italic>in more than 20 African countries including Kenya, Malawi, Uganda, Tanzania, Mozambique, Nigeria, South Africa and Ethiopia. Many other countries have also switched to AL as first-line therapy. The manufacturer introduced price reductions in 2006 and 2008, cutting the public sector price by approximately 50% since 2001.</p><p>Cost-effectiveness assessments, one based on data from a randomized trial in Tanzania [<xref ref-type="bibr" rid="B8">8</xref>] and another based on public health data collected in the field in Zambia [<xref ref-type="bibr" rid="B9">9</xref>], have confirmed that AL offers a cost-effective treatment option compared to other antimalarial drugs.</p><p>Artemether and lumefantrine are lipophilic molecules. Food, especially dietary fat, enhances the bioavailability of both agents, but the effect is more pronounced with lumefantrine [<xref ref-type="bibr" rid="B2">2</xref>]. The fat content of African meals tends to be relatively low; indeed, total fat consumption in sub-Saharan Africa is approximately a third that of Western countries [<xref ref-type="bibr" rid="B10">10</xref>]. This raises the important question of whether adults or children prescribed AL in sub-Saharan Africa consume sufficient fat to ensure parasite clearance. This article reviews the typical components and fat content of African diets and consider the adequacy of fat intake in terms of achieving optimal efficacy.</p><sec><title>Characteristics of lumefantrine absorption</title><p>Lumefantrine, like several other lipophilic antimalarial agents, is absorbed slowly after oral administration, and bioavailability varies between individuals [<xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B11">11</xref>-<xref ref-type="bibr" rid="B13">13</xref>]. Concomitant food increases lumefantrine bioavailability [<xref ref-type="bibr" rid="B14">14</xref>]. In a double-blind trial of 260 patients with uncomplicated malaria in Thailand, Ezzet <italic>et al </italic>showed that both the extent and variability of lumefantrine absorption improved with clinical recovery as normal food intake was resumed [<xref ref-type="bibr" rid="B14">14</xref>]. Oral bioavailability increased by 108% when a normal meal was eaten close to AL dosing, compared to the fasting condition. Adequate lumefantrine absorption is important in order to avoid low plasma concentrations with risk of treatment failure [<xref ref-type="bibr" rid="B2">2</xref>].</p><p>The key question for the healthcare team is how much dietary fat is necessary to achieve complete parasite clearance with AL. This question has been investigated by Ashley <italic>et al </italic>in a cross-over pharmacokinetic study in which lumefantrine exposure (area under the curve, AUC) was measured in healthy volunteers after a single dose of AL was administered with different volumes of soya milk or with no milk [<xref ref-type="bibr" rid="B15">15</xref>]. Based on these data, the authors constructed a population model which indicated that in this population of healthy volunteers, drinking 36 mL of soya milk (containing only 1.2 g of fat) resulted in 90% of the lumefantrine exposure obtained with 500 mL milk (16 g fat); 74 ml of soya milk (2.4 g of fat) achieved 99% of the exposure seen with 500 mL (Figure <xref ref-type="fig" rid="F1">1</xref>). Ashley and colleagues pointed out that 1.2 g of fat can be obtained in a remarkably small amount of food: for example, a single teaspoon of vegetable oil contains 5 g of fat.</p><fig position="float" id="F1"><label>Figure 1</label><caption><p>Relationship between volume of soya milk consumed and estimated lumefantrine absorption (AUC) in healthy volunteers. (Reprinted with permission <ext-link ext-link-type="uri" xlink:href="http://www.blackwellsynergy.com"/>) [<xref ref-type="bibr" rid="B15">15</xref>].</p></caption><graphic xlink:href="1475-2875-7-244-1"/></fig></sec><sec><title>Typical components of African diets</title><p>Diets in Africa vary widely according to regional, economic, environmental and cultural factors. Nevertheless, there are certain typical patterns of food consumption (Table <xref ref-type="table" rid="T1">1</xref>). African diets are traditionally based on a carbohydrate staple that is supplemented by soups, relishes and sauces derived from a wide range of other foodstuffs. The carbohydrate component may be primarily cereals (e.g. maize, sorghum, millet, rice), starchy roots (e.g. potatoes, sweet potatoes, yams, cassava) or fruit (plantain), depending on the country and local area. In recent years there has been a trend away from the consumption of roots towards maize, rice and wheat, particularly in cities [<xref ref-type="bibr" rid="B16">16</xref>]. Accompaniments to the carbohydrate staple are usually composed of vegetables (e.g. eggplant, cabbage, carrots, spinach, kales, French beans, onions), pulses, nuts (particularly peanuts), meat (chicken, beef or pork) or fish, depending on local availability, household income, season and community habits, with the greatest variety seen in coastal regions and the fertile highlands [<xref ref-type="bibr" rid="B16">16</xref>].</p><table-wrap position="float" id="T1"><label>Table 1</label><caption><p>Typical components of regional African diets for adults and infants</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="left"><bold>Region</bold></td><td align="left"><bold>Adults</bold></td><td align="left"><bold>Infants</bold></td></tr></thead><tbody><tr><td align="left">East Africa</td><td align="left">Starchy foods (e.g. cooked bananas, potatoes, cassava, corn, wheat products, rice). Food consumed to accompany starches includes beef, lamb, poultry, stews made of legumes, soups, vegetables (mostly fried in cooking oil or fat or cream) and peanut/groundnut-based sauces</td><td align="left">Exclusively 4&#x02013;6 months unless contraindicated. Weaning may start from month 3 onwards<break/>Supplementary milk from cows<break/>Early food: porridge containing milk or coconut oil.</td></tr><tr><td align="left">West Africa</td><td align="left">Bean balls fried with oil, maize fortified with palm oil, groundnuts, bread, eggs, rice, yam, beef or fish stew, yams, vegetables (mostly fried in cooking oil)</td><td align="left">Exclusively breast-fed up to 4 to 6 months unless contraindicated<break/>Supplementary milk (cow milk or baby formula)<break/>Early foods include chocolate drinks, mashed yam, beans</td></tr><tr><td align="left">Central Africa</td><td align="left">Rice, cassava, sorghum, millet, vegetables (fried in peanut oil), palm oil, fish, meat</td><td align="left">Exclusively breast-fed up to 6 months<break/>Supplementary milk from cows<break/>Early food: porridge from maize meal and milk</td></tr><tr><td align="left">Southern Africa</td><td align="left">Maize, mashed potatoes, vegetables, beef, rice, bread, cassava</td><td align="left">Exclusively breast-fed up to 6 months unless contraindicated<break/>Supplementary milk from cows<break/>Early food: porridge maize meal</td></tr></tbody></table></table-wrap><p>The Food and Agriculture Organization (FAO) of the United Nations compiles data on various aspects of food production and availability [<xref ref-type="bibr" rid="B17">17</xref>]. These statistics offer a valuable source of information, although it should be borne in mind that estimates are based on the amount of food available for human consumption, rather than actual amounts eaten, and do not account for wastage. Table <xref ref-type="table" rid="T2">2</xref> summarizes the consumption of selected food groups in sub-Saharan countries based on FAO data, and highlight the predominance of cereals and starchy root vegetables [<xref ref-type="bibr" rid="B18">18</xref>].</p><table-wrap position="float" id="T2"><label>Table 2</label><caption><p>Average consumption of selected food groups in subSaharan African countries during 2001&#x02013;2003 [<xref ref-type="bibr" rid="B18">18</xref>]</p></caption><table frame="hsides" rules="groups"><thead><tr><td></td><td align="center" colspan="11"><bold>Average intake (g/person/day)</bold></td></tr><tr><td></td><td align="left"><bold>Cereals</bold></td><td align="left"><bold>Fish, seafood</bold></td><td align="left"><bold>Fruit</bold></td><td align="left"><bold>Meat</bold></td><td align="left"><bold>Milk</bold></td><td align="left"><bold>Oilcrops*</bold></td><td align="left"><bold>Pulses</bold></td><td align="left"><bold>Starchy roots</bold></td><td align="left"><bold>Sugars, sweeteners</bold></td><td align="left"><bold>Vegetable oil</bold></td><td align="left"><bold>Vegetables</bold></td></tr></thead><tbody><tr><td align="left">Burkina Faso</td><td align="left">601</td><td align="left">6</td><td align="left">14</td><td align="left">30</td><td align="left">56</td><td align="left">42</td><td align="left">14</td><td align="left">16</td><td align="left">15</td><td align="left">13</td><td align="left">47</td></tr><tr><td align="left">Burundi</td><td align="left">84</td><td align="left">5</td><td align="left">284</td><td align="left">10</td><td align="left">13</td><td align="left">2</td><td align="left">103</td><td align="left">632</td><td align="left">8</td><td align="left">2</td><td align="left">93</td></tr><tr><td align="left">Cameroon</td><td align="left">288</td><td align="left">38</td><td align="left">213</td><td align="left">41</td><td align="left">40</td><td align="left">19</td><td align="left">39</td><td align="left">400</td><td align="left">28</td><td align="left">21</td><td align="left">217</td></tr><tr><td align="left">Congo, Dem Republic of</td><td align="left">102</td><td align="left">16</td><td align="left">82</td><td align="left">13</td><td align="left">4</td><td align="left">12</td><td align="left">10</td><td align="left">842</td><td align="left">8</td><td align="left">15</td><td align="left">25</td></tr><tr><td align="left">C&#x000f4;te d'Ivoire</td><td align="left">331</td><td align="left">40</td><td align="left">201</td><td align="left">31</td><td align="left">21</td><td align="left">20</td><td align="left">1</td><td align="left">619</td><td align="left">30</td><td align="left">37</td><td align="left">103</td></tr><tr><td align="left">Ethiopia</td><td align="left">384</td><td align="left">1</td><td align="left">28</td><td align="left">23</td><td align="left">61</td><td align="left">2</td><td align="left">35</td><td align="left">168</td><td align="left">12</td><td align="left">4</td><td align="left">31</td></tr><tr><td align="left">Ghana</td><td align="left">249</td><td align="left">80</td><td align="left">319</td><td align="left">27</td><td align="left">21</td><td align="left">35</td><td align="left">2</td><td align="left">1107</td><td align="left">19</td><td align="left">16</td><td align="left">88</td></tr><tr><td align="left">Kenya</td><td align="left">337</td><td align="left">12</td><td align="left">154</td><td align="left">40</td><td align="left">263</td><td align="left">4</td><td align="left">42</td><td align="left">164</td><td align="left">55</td><td align="left">20</td><td align="left">102</td></tr><tr><td align="left">Malawi</td><td align="left">403</td><td align="left">10</td><td align="left">107</td><td align="left">14</td><td align="left">12</td><td align="left">13</td><td align="left">34</td><td align="left">504</td><td align="left">31</td><td align="left">9</td><td align="left">54</td></tr><tr><td align="left">Mali</td><td align="left">502</td><td align="left">21</td><td align="left">8</td><td align="left">51</td><td align="left">126</td><td align="left">5</td><td align="left">25</td><td align="left">30</td><td align="left">30</td><td align="left">18</td><td align="left">66</td></tr><tr><td align="left">Mozambique</td><td align="left">289</td><td align="left">6</td><td align="left">48</td><td align="left">15</td><td align="left">12</td><td align="left">5</td><td align="left">26</td><td align="left">665</td><td align="left">31</td><td align="left">19</td><td align="left">17</td></tr><tr><td align="left">Nigeria</td><td align="left">399</td><td align="left">20</td><td align="left">185</td><td align="left">23</td><td align="left">20</td><td align="left">21</td><td align="left">26</td><td align="left">593</td><td align="left">31</td><td align="left">38</td><td align="left">167</td></tr><tr><td align="left">Sudan</td><td align="left">370</td><td align="left">5</td><td align="left">83</td><td align="left">59</td><td align="left">410</td><td align="left">11</td><td align="left">22</td><td align="left">13</td><td align="left">55</td><td align="left">21</td><td align="left">135</td></tr><tr><td align="left">Uganda</td><td align="left">170</td><td align="left">20</td><td align="left">556</td><td align="left">31</td><td align="left">67</td><td align="left">35</td><td align="left">65</td><td align="left">561</td><td align="left">24</td><td align="left">5</td><td align="left">55</td></tr><tr><td align="left">United Republic of Tanzania</td><td align="left">307</td><td align="left">19</td><td align="left">81</td><td align="left">27</td><td align="left">70</td><td align="left">13</td><td align="left">28</td><td align="left">518</td><td align="left">21</td><td align="left">14</td><td align="left">76</td></tr><tr><td align="left">Zimbabwe</td><td align="left">355</td><td align="left">4</td><td align="left">32</td><td align="left">42</td><td align="left">54</td><td align="left">17</td><td align="left">13</td><td align="left">43</td><td align="left">97</td><td align="left">26</td><td align="left">30</td></tr></tbody></table><table-wrap-foot><p>* Excluding products</p></table-wrap-foot></table-wrap><p>The most important sources of dietary fat in African countries are oil crops (e.g. peanuts, soy beans) and oils obtained from vegetables or plants such as red palm oil, groundnut oil, coconut oil and sesame oil. These are widely used in food preparation, for frying or as additions to sauces and stews. Additional contributions to fat intake are made by other commonly-used foodstuffs such as nuts and pulses. Table <xref ref-type="table" rid="T3">3</xref> describes the typical fat content of some staple foodstuffs [<xref ref-type="bibr" rid="B19">19</xref>]. While food composition inevitably varies according to crop variety, growing conditions and freshness, these illustrate that relatively small amounts of certain widely-consumed items such as soya beans and ground nuts contain high levels of fat. A further contribution comes from whole-grain cereals if the cereal germ is not separated out prior to milling: for example, maize contains 4.8 g/100 g [<xref ref-type="bibr" rid="B19">19</xref>] and is a staple food in many countries.</p><table-wrap position="float" id="T3"><label>Table 3</label><caption><p>Fat content of typical foodstuffs [<xref ref-type="bibr" rid="B19">19</xref>]</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="left"><bold>Type</bold></td><td align="left"><bold>Food</bold></td><td align="left"><bold>Fat content (g/100 g)</bold></td></tr></thead><tbody><tr><td align="left">Carbohydrates and legumes</td><td align="left">Maize</td><td align="left">4.8</td></tr><tr><td></td><td align="left">Millet</td><td align="left">3.5</td></tr><tr><td></td><td align="left">Rice</td><td align="left">0.5</td></tr><tr><td></td><td align="left">Sorghum</td><td align="left">3.2</td></tr><tr><td></td><td align="left">Wheat flour</td><td align="left">2.0</td></tr><tr><td></td><td align="left">Cassava meal</td><td align="left">0.5</td></tr><tr><td></td><td align="left">Beans</td><td align="left">1.5</td></tr><tr><td></td><td align="left">Lentil</td><td align="left">1.2</td></tr><tr><td></td><td align="left">Pigeon peas</td><td align="left">1.3</td></tr><tr><td></td><td align="left">Soya beans</td><td align="left">18.0</td></tr><tr><td></td><td align="left">Yam</td><td align="left">0.1</td></tr><tr><td align="left">Meat/fish</td><td align="left">Beef</td><td align="left">18.0</td></tr><tr><td></td><td align="left">Chicken</td><td align="left">6.5</td></tr><tr><td></td><td align="left">Eggs</td><td align="left">10.0</td></tr><tr><td></td><td align="left">Fish</td><td align="left">7.4</td></tr><tr><td align="left">Nuts/fruit</td><td align="left">Peanuts</td><td align="left">45.0</td></tr><tr><td></td><td align="left">Coconut</td><td align="left">35.0</td></tr><tr><td></td><td align="left">Sunflower</td><td align="left">46.0</td></tr><tr><td></td><td align="left">Avocado</td><td align="left">18.0</td></tr></tbody></table></table-wrap></sec><sec><title>Total fat intake in African countries</title><p>Total energy intake per person across sub-Saharan Africa is currently estimated to be 2220 kcal/day, compared to 3340 kcal/day in developed countries [<xref ref-type="bibr" rid="B10">10</xref>]. Regional differences exist, most notably a higher average energy intake in West Africa compared to other areas (Table <xref ref-type="table" rid="T4">4</xref>). Estimates of total fat intake from the FAO for the period 2001&#x02013;2003 suggest that the average total amount of fat consumed per person per day vary considerably between subSaharan African countries (Table <xref ref-type="table" rid="T5">5</xref>) [<xref ref-type="bibr" rid="B10">10</xref>]. The majority of countries, however, fall into the range 30&#x02013;60 g/person/day. The daily intake of fat across subSaharan Africa is estimated to be 43 g/person/day, with the highest fat intake in West Africa (Table <xref ref-type="table" rid="T1">1</xref>); for comparison, people in developed countries consume 123 g/person/day, on average [<xref ref-type="bibr" rid="B10">10</xref>]. The per capita daily intake of fat has generally remained stable or shown an upward trend in the majority of African countries over the last three decades [<xref ref-type="bibr" rid="B10">10</xref>], with exceptions being due to major conflicts or famines.</p><table-wrap position="float" id="T4"><label>Table 4</label><caption><p>Average dietary energy and fat consumption in regions of Africa. [<xref ref-type="bibr" rid="B10">10</xref>]</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="left"><bold>Region</bold></td><td align="left"><bold>Dietary energy consumption</bold><break/><bold>(kCal/person/day)</bold></td><td align="left"><bold>Dietary fat consumption</bold><break/><bold>(kCal/person/day)</bold></td></tr></thead><tbody><tr><td align="left">SubSaharan Africa</td><td align="left">2220</td><td align="left">43</td></tr><tr><td align="left">Central Africa</td><td align="left">1830</td><td align="left">36</td></tr><tr><td align="left">East Africa</td><td align="left">2040</td><td align="left">35</td></tr><tr><td align="left">Southern Africa</td><td align="left">2080</td><td align="left">36</td></tr><tr><td align="left">West Africa</td><td align="left">2580</td><td align="left">57</td></tr></tbody></table></table-wrap><table-wrap position="float" id="T5"><label>Table 5</label><caption><p>Average dietary fat consumption in sub-Saharan African countries during 2001&#x02013;2003 [<xref ref-type="bibr" rid="B10">10</xref>]</p></caption><table frame="hsides" rules="groups"><thead><tr><td></td><td align="left"><bold>Total fat consumption (g/person/day)</bold></td></tr></thead><tbody><tr><td align="left">Burkina Faso</td><td align="left">56</td></tr><tr><td align="left">Burundi</td><td align="left">10</td></tr><tr><td align="left">Cameroon</td><td align="left">46</td></tr><tr><td align="left">Congo, Democratic Republic of</td><td align="left">26</td></tr><tr><td align="left">C&#x000f4;te d'Ivoire</td><td align="left">59</td></tr><tr><td align="left">Ethiopia</td><td align="left">20</td></tr><tr><td align="left">Ghana</td><td align="left">38</td></tr><tr><td align="left">Kenya</td><td align="left">49</td></tr><tr><td align="left">Malawi</td><td align="left">33</td></tr><tr><td align="left">Mali</td><td align="left">46</td></tr><tr><td align="left">Mozambique</td><td align="left">33</td></tr><tr><td align="left">Nigeria</td><td align="left">63</td></tr><tr><td align="left">Sudan</td><td align="left">69</td></tr><tr><td align="left">Uganda</td><td align="left">32</td></tr><tr><td align="left">United Republic of Tanzania</td><td align="left">31</td></tr><tr><td align="left">Zimbabwe</td><td align="left">55</td></tr></tbody></table></table-wrap></sec><sec><title>Fat content of breast milk and weaning foods</title><p>It is standard to breast-feed infants up to 4&#x02013;6 months in all regions of Africa, although supplementary cow's milk may be given. The fat content of breast milk in rural African areas varies with the season, stage of lactation and between individual mothers, but an investigation in a farming community in The Gambia recorded an average fat content of 40 g/L breast milk [<xref ref-type="bibr" rid="B20">20</xref>], similar to that reported in other parts of the world [<xref ref-type="bibr" rid="B21">21</xref>-<xref ref-type="bibr" rid="B23">23</xref>]. Breast-fed infants in The Gambia have been shown to receive 15&#x02013;30 g fat/day from breast milk up to the age of 18 months, with breast milk continuing to make a major contribution to fat intake even after partial weaning [<xref ref-type="bibr" rid="B24">24</xref>]. Comparing infants in The Gambia and the United Kingdom, Prentice <italic>et al </italic>found that fat intake from breast milk was at least as high in the Gambian children while being breast-fed exclusively [<xref ref-type="bibr" rid="B24">24</xref>].</p><p>Infants usually continue to receive breast milk until two years of age, with some food introduced from three months or later. The first weaning food is usually porridge made from a cereal such as rice, corn or millet mixed with water, or possibly cow's milk, with salt and sugar. Such porridges have a relatively low fat content (e.g. 0.1&#x02013;0.3 g/100 g); although addition of soya milk or peanuts in some regions increases the fat content (1.2&#x02013;1.9 g/100 g) [<xref ref-type="bibr" rid="B25">25</xref>]. In West Africa there tends to be a greater diversity of early foodstuffs, including chocolate, mashed potatoes or beans (Table <xref ref-type="table" rid="T1">1</xref>).</p><p>The transition from breast milk to weaning foods and then to adult foods is associated with a marked reduction in the proportion of energy that is obtained from fat. A study in Kenya was undertaken in infants during the second year of life (mean 14&#x02013;20 months) to assess fat intake over the period of weaning [<xref ref-type="bibr" rid="B26">26</xref>]. In these young children, the mean quantity of breast milk ingested was calculated to be 502 &#x000b1; 239 g per 24 hours, although this varied widely between individuals [<xref ref-type="bibr" rid="B26">26</xref>]. The authors calculated the average fat intake from milk to be approximately 17 g/day, which was supplemented by 10.5 g/day from weaning foods. In the period prior to weaning, fat intake from breast milk decreased to approximately 11 g/day but after complete weaning the increased food consumption provided only an additional 3.5 g/day. A further detailed study in The Gambia has shown that total fat intake remained relatively stable over the first 17 months of life, but as the percentage of other foods (notably cereals and peanuts) increased in the diet, the percentage of energy from fat decreased from 50% during breast-feeding to 30% during mixed feeding and to 15% after total weaning [<xref ref-type="bibr" rid="B24">24</xref>]. Nevertheless, total fat intake, which was ~25 g/day until complete weaning, was &#x0003e;10 g/day subsequently.</p><p>Cow's milk is only given to infants infrequently in many African countries because of the low milk yield per animal and scarcity of preservation equipment, although it is more common in some countries (e.g. Kenya, Somalia and Sudan). Where cow's milk is used, however, it is a good source of fat with a fat content of 30 g/L [<xref ref-type="bibr" rid="B19">19</xref>], only slightly lower than breast milk.</p></sec><sec><title>Relevant experience from clinical trials</title><p>In most trials of AL in African populations, AL has been administered under supervision with food or drink given in the hospital or clinic [<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B7">7</xref>,<xref ref-type="bibr" rid="B27">27</xref>-<xref ref-type="bibr" rid="B29">29</xref>]. Two studies, however, have assessed 'real-life effectiveness' of AL, in which the drug was taken unsupervised at home [<xref ref-type="bibr" rid="B6">6</xref>,<xref ref-type="bibr" rid="B30">30</xref>]. These are helpful in providing an indication of whether normal, unsupervised food consumption during AL administration ensures good efficacy. Piola <italic>et al </italic>undertook a randomized trial in 957 patients in Uganda to compare the effectiveness of AL when administered under supervision in hospital with fat intake ensured by a meal comprising ~300 mL milk (10 g fat) with 30 g peanuts (13 g fat) versus AL taken unsupervised at home [<xref ref-type="bibr" rid="B6">6</xref>]. In the unsupervised group, only the first dose was taken in the clinic, and patients were then discharged and advised to take subsequent doses with a meal that contained fat (with no fat content specified), or breast milk in breastfed infants. The 28-day PCR-corrected cure rate in the evaluable population was 100% in both cohorts (95% CI 98&#x02013;100 in the supervised group and 99&#x02013;100 in the unsupervised group). The type of meal eaten at home was not recorded, so it cannot be determined if patients ate especially fatty meals or standard food. Lumefantrine plasma concentration was measured on days 3 and 7 in a random selection of 433 patients taking part in the study [<xref ref-type="bibr" rid="B31">31</xref>], and multivariate modelling of these data confirmed that supervised treatment was significantly associated with higher lumefantrine concentrations (p &#x0003c; 0.0001) [<xref ref-type="bibr" rid="B31">31</xref>]. In another trial, undertaken in an area of Tanzania with a high level of resistance to sulfadoxine-pyrimethamine and amodiaquine, Mutabingwa and colleagues randomized 1292 children aged 4&#x02013;59 months with uncomplicated malaria to AL or to conventional drugs [<xref ref-type="bibr" rid="B30">30</xref>]. All agents were taken at home, without supervision, and no specific advice was given regarding concomitant food consumption. At 28 days, 97.3% of patients receiving AL showed parasitological cure after adjustment for recrudescence.</p><p>Together, these findings suggest that food consumption during unsupervised AL dosing in African patients, including children, provides sufficient fat to ensure effective parasitological clearance.</p><p>As discussed above, the fat consumption of infants shortly after weaning can be relatively low. It is highly relevant, therefore, that randomized trials in African children aged from five months [<xref ref-type="bibr" rid="B32">32</xref>,<xref ref-type="bibr" rid="B33">33</xref>] or 12 months [<xref ref-type="bibr" rid="B34">34</xref>] up to 59 months have consistently shown 28-day PCR-corrected parasitological cure rates of greater than 95% i.e. similar to cure rates observed in older populations.</p><p>It should be noted that data are scarce concerning lumefantrine absorption, and the effect of food consumption, in patients with HIV/AIDs or other coinfections such as tuberculosis. Pharmacokinetic and pharmacodynamic studies are required in the HIV/AIDS population, particularly in the light of increased antimalarial failure rates in such patients due to increased parasite burden and reduced host immunity associated with HIV infection (1).</p></sec></sec><sec><title>Conclusion</title><p>Although lumefantrine bioavailability is enhanced by fat, pharmacokinetic evidence suggests that only a very small amount of dietary fat is required [<xref ref-type="bibr" rid="B15">15</xref>]. In the event of varying dietary fat intake, such as during unsupervised dosing where fat consumption was not controlled [<xref ref-type="bibr" rid="B6">6</xref>] or was not specifically advised [<xref ref-type="bibr" rid="B30">30</xref>], the efficacy of AL does not appear to have been impaired. This is consistent with published statistics concerning the dietary fat intake of African populations, which indicate that average fat consumption is generally in the range of 30&#x02013;60 g/day in subSaharan African countries. Even in young children shortly after weaning, in whom fat intake tends to be low, it has been estimated that fat intake exceeds 10 g/day. In summary, there is good evidence to suggest that the content of standard African diets or breast milk is adequate to ensure excellent efficacy for AL.</p></sec><sec><title>Abbreviations</title><p>ACT: artemisinin-based combination treatment; AL: artemether-lumefantrine; AUC: area under the curve; FAO: Food and Agriculture Organization; PCR: polymerase chain reaction.</p></sec><sec><title>Competing interests</title><p>The authors declare that they have no competing interests other than COF, who received a research grant from Novartis in 2002, and NM and ON, who are employees of Novartis Pharma AG.</p></sec><sec><title>Authors' contributions</title><p>All authors provided critical review of the text and approved the final version.</p></sec></body><back><ref-list><ref id="B1"><citation citation-type="book"><person-group person-group-type="author"><collab>World Health Organization</collab></person-group><source>Guidelines for treatment of malaria</source><year>2006</year><publisher-name>Geneva: World Health Organization</publisher-name></citation></ref><ref id="B2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>White</surname><given-names>NJ</given-names></name><name><surname>van Vugt</surname><given-names>M</given-names></name><name><surname>Ezzet</surname><given-names>F</given-names></name></person-group><article-title>Clinical pharmacokinetics and pharmacodynamics and pharmacodynamics of artemether-lumefantrine</article-title><source>Clin Pharmacokinet</source><year>1999</year><volume>37</volume><fpage>105</fpage><lpage>125</lpage><pub-id pub-id-type="pmid">10496300</pub-id><pub-id pub-id-type="doi">10.2165/00003088-199937020-00002</pub-id></citation></ref><ref id="B3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Makanga</surname><given-names>M</given-names></name><name><surname>Premji</surname><given-names>Z</given-names></name><name><surname>Falade</surname><given-names>C</given-names></name><name><surname>Karbwang</surname><given-names>J</given-names></name><name><surname>Mueller</surname><given-names>EA</given-names></name><name><surname>Andriano</surname><given-names>K</given-names></name><name><surname>Hunt</surname><given-names>P</given-names></name><name><surname>De Palacios</surname><given-names>PI</given-names></name></person-group><article-title>Efficacy and safety of the six-dose regimen of arthemeter-lumefrantrine in pediatrics with uncomplicated <italic>Plasmodium fulciparum </italic>malaria: a pooled analysis of individual patient data</article-title><source>Am J Trop Med Hyg</source><year>2006</year><volume>74</volume><fpage>991</fpage><lpage>998</lpage><pub-id pub-id-type="pmid">16760509</pub-id></citation></ref><ref id="B4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Falade</surname><given-names>C</given-names></name><name><surname>Makanga</surname><given-names>M</given-names></name><name><surname>Premji</surname><given-names>Z</given-names></name><name><surname>Ortmann</surname><given-names>CE</given-names></name><name><surname>Stockmeyer</surname><given-names>M</given-names></name><name><surname>de Palacios</surname><given-names>PI</given-names></name></person-group><article-title>Efficacy and safety of artemether-lumefantrine (Coartem<sup>&#x000ae;</sup>) tablets (six-dose regimen) in African infants and children with acute, uncomplicated falciparum malaria</article-title><source>Trans R Soc Trop Med Hyg</source><year>2005</year><volume>99</volume><fpage>459</fpage><lpage>467</lpage><pub-id pub-id-type="pmid">15837358</pub-id><pub-id pub-id-type="doi">10.1016/j.trstmh.2004.09.013</pub-id></citation></ref><ref id="B5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dorsey</surname><given-names>G</given-names></name><name><surname>Staedke</surname><given-names>S</given-names></name><name><surname>Clark</surname><given-names>TD</given-names></name><name><surname>Njama-Meya</surname><given-names>D</given-names></name><name><surname>Nzarubara</surname><given-names>B</given-names></name><name><surname>Maiteki-Sebuguzi</surname><given-names>C</given-names></name><name><surname>Dokomajilar</surname><given-names>C</given-names></name><name><surname>Kamya</surname><given-names>MR</given-names></name><name><surname>Rosenthal</surname><given-names>PJ</given-names></name></person-group><article-title>Combination therapy for uncomplicated falciparum malaria in Ugandan children: a randomized trial</article-title><source>JAMA</source><year>2007</year><volume>297</volume><fpage>2210</fpage><lpage>2219</lpage><pub-id pub-id-type="pmid">17519410</pub-id><pub-id pub-id-type="doi">10.1001/jama.297.20.2210</pub-id></citation></ref><ref id="B6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Piola</surname><given-names>P</given-names></name><name><surname>Fogg</surname><given-names>C</given-names></name><name><surname>Bajunirwe</surname><given-names>F</given-names></name><name><surname>Biraro</surname><given-names>S</given-names></name><name><surname>Grandesso</surname><given-names>F</given-names></name><name><surname>Ruzagira</surname><given-names>E</given-names></name><name><surname>Babigumira</surname><given-names>J</given-names></name><name><surname>Kigozi</surname><given-names>I</given-names></name><name><surname>Kiguli</surname><given-names>J</given-names></name><name><surname>Kyomuhendo</surname><given-names>J</given-names></name><name><surname>Ferradini</surname><given-names>L</given-names></name><name><surname>Taylor</surname><given-names>W</given-names></name><name><surname>Checchi</surname><given-names>F</given-names></name><name><surname>Guthmann</surname><given-names>JP</given-names></name></person-group><article-title>Supervised versus unsupervised intake of six-dose artemether-lumefantrine for treatment of acute, uncomplicated <italic>Plasmodium falciparum </italic>malaria in Mbarara, Uganda: a randomized trial</article-title><source>Lancet</source><year>2005</year><volume>365</volume><fpage>1467</fpage><lpage>1473</lpage><pub-id pub-id-type="pmid">15850630</pub-id><pub-id pub-id-type="doi">10.1016/S0140-6736(05)66416-1</pub-id></citation></ref><ref id="B7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Abdulla</surname><given-names>S</given-names></name><name><surname>Sagara</surname><given-names>I</given-names></name><name><surname>Borrmann</surname><given-names>S</given-names></name><name><surname>D'Alessandro</surname><given-names>U</given-names></name><name><surname>Gonz&#x000e1;lez</surname><given-names>R</given-names></name><name><surname>Hamel</surname><given-names>M</given-names></name><name><surname>Ogutu</surname><given-names>B</given-names></name><name><surname>M&#x000e5;rtensson</surname><given-names>A</given-names></name><name><surname>Lyimo</surname><given-names>J</given-names></name><name><surname>Maiga</surname><given-names>H</given-names></name><name><surname>Sasi</surname><given-names>P</given-names></name><name><surname>Nahum</surname><given-names>A</given-names></name><name><surname>Bassat</surname><given-names>Q</given-names></name><name><surname>Juma</surname><given-names>E</given-names></name><name><surname>Otieno</surname><given-names>L</given-names></name><name><surname>Bj&#x000f6;rkman</surname><given-names>A</given-names></name><name><surname>Beck</surname><given-names>HP</given-names></name><name><surname>Andriano</surname><given-names>K</given-names></name><name><surname>Cousin</surname><given-names>M</given-names></name><name><surname>Lef&#x000e8;vre</surname><given-names>G</given-names></name><name><surname>Ubben</surname><given-names>D</given-names></name><name><surname>Premji</surname><given-names>Z</given-names></name></person-group><article-title>Efficacy and safety of artemether-lumefantrine dispersible tablet in African infants and children with uncomplicated malaria : a randomised, investigator-blinded, multi-centre comparison with the crushed commercial tablet</article-title><source>Lancet</source><year>2008</year><comment></comment><pub-id pub-id-type="pmid">18926569</pub-id></citation></ref><ref id="B8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wiseman</surname><given-names>V</given-names></name><name><surname>Kim</surname><given-names>M</given-names></name><name><surname>Mutabingwa</surname><given-names>TK</given-names></name><name><surname>Whitty</surname><given-names>CJ</given-names></name></person-group><article-title>Cost-effectiveness study of three antimalarial drug combinations in Tanzania</article-title><source>PLoS Med</source><year>2006</year><volume>3</volume><fpage>e373</fpage><pub-id pub-id-type="pmid">17032059</pub-id><pub-id pub-id-type="doi">10.1371/journal.pmed.0030373</pub-id></citation></ref><ref id="B9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chanda</surname><given-names>P</given-names></name><name><surname>Masiye</surname><given-names>F</given-names></name><name><surname>Chitah</surname><given-names>BM</given-names></name><name><surname>Sipilanyambe</surname><given-names>N</given-names></name><name><surname>Hawela</surname><given-names>N</given-names></name><name><surname>Banda</surname><given-names>P</given-names></name><name><surname>Okorosobo</surname><given-names>T</given-names></name></person-group><article-title>A cost-effectiveness analysis of artemether lumefantrine for treatment of uncomplicated malaria in Zambia</article-title><source>Malar J</source><year>2007</year><volume>6</volume><fpage>21</fpage><pub-id pub-id-type="pmid">17313682</pub-id><pub-id pub-id-type="doi">10.1186/1475-2875-6-21</pub-id></citation></ref><ref id="B10"><citation citation-type="other"><article-title>Food and Agriculture Organization of the United Nations Statistics Division</article-title><ext-link ext-link-type="uri" xlink:href="http://www.fao.org/faostat/foodsecurity/Files/FoodConsumptionNutrients_en.xls"/><comment>Accessed April 2008</comment></citation></ref><ref id="B11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lef&#x000e8;vre</surname><given-names>G</given-names></name><name><surname>Thomsen</surname><given-names>MS</given-names></name></person-group><article-title>Clinical pharmacokinetics of artemether and lumefantrine (Riamet<sup>&#x000ae;</sup>)</article-title><source>Clin Drug Invest</source><year>1999</year><volume>18</volume><fpage>467</fpage><lpage>480</lpage><pub-id pub-id-type="doi">10.2165/00044011-199918060-00006</pub-id></citation></ref><ref id="B12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ezzet</surname><given-names>F</given-names></name><name><surname>van Vugt</surname><given-names>M</given-names></name><name><surname>Nosten</surname><given-names>F</given-names></name><name><surname>Looareesuwan</surname><given-names>S</given-names></name><name><surname>White</surname><given-names>NJ</given-names></name></person-group><article-title>Pharmacokinetics and pharmacodynamics of lumefantrine (benflumetol) in acute falciparum malaria</article-title><source>Antimicrob Agents Chemother</source><year>2000</year><volume>44</volume><fpage>697</fpage><lpage>704</lpage><pub-id pub-id-type="pmid">10681341</pub-id><pub-id pub-id-type="doi">10.1128/AAC.44.3.697-704.2000</pub-id></citation></ref><ref id="B13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schmidt</surname><given-names>LE</given-names></name><name><surname>Dalhoff</surname><given-names>K</given-names></name></person-group><article-title>Food-drug interactions</article-title><source>Drugs</source><year>2002</year><volume>62</volume><fpage>1481</fpage><lpage>1502</lpage><pub-id pub-id-type="pmid">12093316</pub-id><pub-id pub-id-type="doi">10.2165/00003495-200262100-00005</pub-id></citation></ref><ref id="B14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ezzet</surname><given-names>F</given-names></name><name><surname>Mull</surname><given-names>R</given-names></name><name><surname>Karbwang</surname><given-names>J</given-names></name></person-group><article-title>Population pharmacokinetics and therapeutic response of CGP 56697 (artemether + benflumetol) in malaria patients</article-title><source>Br J Clin Pharmacol</source><year>1998</year><volume>46</volume><fpage>553</fpage><lpage>561</lpage><pub-id pub-id-type="pmid">9862244</pub-id><pub-id pub-id-type="doi">10.1046/j.1365-2125.1998.00830.x</pub-id></citation></ref><ref id="B15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ashley</surname><given-names>EA</given-names></name><name><surname>Stepniewska</surname><given-names>K</given-names></name><name><surname>Lindeg&#x000e5;rdh</surname><given-names>N</given-names></name><name><surname>Annerberg</surname><given-names>A</given-names></name><name><surname>Kham</surname><given-names>A</given-names></name><name><surname>Brockman</surname><given-names>A</given-names></name><name><surname>Singhasivanon</surname><given-names>P</given-names></name><name><surname>White</surname><given-names>NJ</given-names></name><name><surname>Nosten</surname><given-names>F</given-names></name></person-group><article-title>How much fat is necessary to optimize lumefantrine oral bioavailability?</article-title><source>Trop Med Int Health</source><year>2007</year><volume>12</volume><fpage>195</fpage><lpage>200</lpage><pub-id pub-id-type="pmid">17300625</pub-id></citation></ref><ref id="B16"><citation citation-type="other"><article-title>Food and Agriculture Organization Corporate Document Repository. Agriculture, <italic>Food and Nutrition for Africa: A Resource Book for Teachers of Africa</italic>. Chapter 7: Food, nutrients and Diets</article-title><ext-link ext-link-type="uri" xlink:href="http://www.fao.org/docrep/W0078E/w0078e08.htm#P7404_499006"/><comment>Accessed April 2008</comment></citation></ref><ref id="B17"><citation citation-type="other"><article-title>Food and Agriculture Organization of the United Nations</article-title><ext-link ext-link-type="uri" xlink:href="http://www.fao.org/"/><comment>Accessed April 2008</comment></citation></ref><ref id="B18"><citation citation-type="other"><article-title>Food and Agriculture Organization of the United Nations. Food Consumption Food Groups</article-title><ext-link ext-link-type="uri" xlink:href="http://www.fao.org/faostat/foodsecurity/Files/FoodConsumptionFoodGroups_en.xls"/><comment>Accessed April 2008</comment></citation></ref><ref id="B19"><citation citation-type="other"><article-title>Food and Agriculture Organization of the United Nations/US Department of Health, Education and Welfare</article-title><source>Food Composition Table for Use in Africa</source><ext-link ext-link-type="uri" xlink:href="http://www.fao.org/docrep/003/X6877E/X6877E00.htm#"/><comment>Accessed April 2008</comment></citation></ref><ref id="B20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Prentice</surname><given-names>A</given-names></name><name><surname>Prentice</surname><given-names>AM</given-names></name><name><surname>Whitehead</surname><given-names>RG</given-names></name></person-group><article-title>Breast-milk fat concentrations of rural African women. 2. Long-term variations within a community</article-title><source>Br J Nutr</source><year>1981</year><volume>45</volume><fpage>495</fpage><lpage>503</lpage><pub-id pub-id-type="pmid">7236578</pub-id><pub-id pub-id-type="doi">10.1079/BJN19810128</pub-id></citation></ref><ref id="B21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kent</surname><given-names>JC</given-names></name><name><surname>Mitoulas</surname><given-names>LR</given-names></name><name><surname>Cregan</surname><given-names>MD</given-names></name><name><surname>Ramsay</surname><given-names>DT</given-names></name><name><surname>Doherty</surname><given-names>DA</given-names></name><name><surname>Hartmann</surname><given-names>PE</given-names></name></person-group><article-title>Volume and frequency of breastfeedings and fat content of breast milk throughout the day</article-title><source>Pediatrics</source><year>2006</year><volume>117</volume><fpage>e387</fpage><lpage>395</lpage><pub-id pub-id-type="pmid">16510619</pub-id><pub-id pub-id-type="doi">10.1542/peds.2005-1417</pub-id></citation></ref><ref id="B22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Larnkjaer</surname><given-names>A</given-names></name><name><surname>Schack-Nielsen</surname><given-names>L</given-names></name><name><surname>Michaelsen</surname><given-names>KF</given-names></name></person-group><article-title>Fat content in human milk according to duration of lactation</article-title><source>Pediatrics</source><year>2006</year><volume>117</volume><fpage>988</fpage><lpage>989</lpage><pub-id pub-id-type="pmid">16510690</pub-id><pub-id pub-id-type="doi">10.1542/peds.2005-2929</pub-id></citation></ref><ref id="B23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liyanage</surname><given-names>C</given-names></name><name><surname>Hettiarachchi</surname><given-names>M</given-names></name><name><surname>Mangalajeewa</surname><given-names>P</given-names></name><name><surname>Malawipathirana</surname><given-names>S</given-names></name></person-group><article-title>Adequacy of vitamin A and fat in the breast milk of lactating women in south Sri Lanka</article-title><source>Public Health Nutr</source><year>2008</year><comment></comment><pub-id pub-id-type="pmid">18312705</pub-id></citation></ref><ref id="B24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Prentice</surname><given-names>AM</given-names></name><name><surname>Paul</surname><given-names>AA</given-names></name></person-group><article-title>Fat and energy needs of children in developing countries</article-title><source>Am J Clin Nutr</source><year>2000</year><volume>72</volume><fpage>1253S</fpage><lpage>1265S</lpage><pub-id pub-id-type="pmid">11063467</pub-id></citation></ref><ref id="B25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hudson</surname><given-names>GJ</given-names></name><name><surname>John</surname><given-names>PMV</given-names></name><name><surname>Paul</surname><given-names>AA</given-names></name></person-group><article-title>Variation in the composition of Gambian foods; the importance of water in relation to energy and protein content</article-title><source>Ecol Food Nutr</source><year>1980</year><volume>10</volume><fpage>9</fpage><lpage>17</lpage></citation></ref><ref id="B26"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Onyango</surname><given-names>AW</given-names></name><name><surname>Receveur</surname><given-names>O</given-names></name><name><surname>Esrey</surname><given-names>SA</given-names></name></person-group><article-title>The contribution of breast milk to toddler diets in western Kenya</article-title><source>Bull World Health Organ</source><year>2002</year><volume>80</volume><fpage>292</fpage><lpage>299</lpage><pub-id pub-id-type="pmid">12075365</pub-id></citation></ref><ref id="B27"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>von Seidlein</surname><given-names>L</given-names></name><name><surname>Jaffar</surname><given-names>S</given-names></name><name><surname>Pinder</surname><given-names>M</given-names></name><name><surname>Haywood</surname><given-names>M</given-names></name><name><surname>Snounou</surname><given-names>G</given-names></name><name><surname>Gemperli</surname><given-names>B</given-names></name><name><surname>Gathmann</surname><given-names>I</given-names></name><name><surname>Royce</surname><given-names>C</given-names></name><name><surname>Greenwood</surname><given-names>B</given-names></name></person-group><article-title>Treatment of African children with uncomplicated falciparum</article-title><source>J Infect Dis</source><year>1997</year><volume>176</volume><fpage>1113</fpage><lpage>1116</lpage><pub-id pub-id-type="pmid">9333180</pub-id></citation></ref><ref id="B28"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>von Seidlein</surname><given-names>L</given-names></name><name><surname>Bojang</surname><given-names>K</given-names></name><name><surname>Jones</surname><given-names>P</given-names></name><name><surname>Jaffar</surname><given-names>S</given-names></name><name><surname>Pinder</surname><given-names>M</given-names></name><name><surname>Obaro</surname><given-names>S</given-names></name><name><surname>Doherty</surname><given-names>T</given-names></name><name><surname>Haywood</surname><given-names>M</given-names></name><name><surname>Snounou</surname><given-names>G</given-names></name><name><surname>Gemperli</surname><given-names>B</given-names></name><name><surname>Gathmann</surname><given-names>I</given-names></name><name><surname>Royce</surname><given-names>C</given-names></name><name><surname>McAdam</surname><given-names>K</given-names></name><name><surname>Greenwood</surname><given-names>B</given-names></name></person-group><article-title>A randomized controlled trial of artemether/benflumetol, a new anti-malarial and pyrimethamine/sulfadoxine in the treatment of uncomplicated falciparum malaria in African children</article-title><source>Am J Trop Med Hyg</source><year>1998</year><volume>58</volume><fpage>638</fpage><lpage>644</lpage><pub-id pub-id-type="pmid">9598454</pub-id></citation></ref><ref id="B29"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hatz</surname><given-names>C</given-names></name><name><surname>Abdulla</surname><given-names>S</given-names></name><name><surname>Mull</surname><given-names>R</given-names></name><name><surname>Schellenberg</surname><given-names>D</given-names></name><name><surname>Gathmann</surname><given-names>I</given-names></name><name><surname>Kibatala</surname><given-names>P</given-names></name><name><surname>Beck</surname><given-names>HP</given-names></name><name><surname>Tanner</surname><given-names>M</given-names></name><name><surname>Royce</surname><given-names>C</given-names></name></person-group><article-title>Efficacy and safety of CGP 56697 (artemether and benflumetol) compared with chloroquine to treat acute falciparum malaria in Tanzanian children aged 1&#x02013;5 years</article-title><source>Trop Med Int Health</source><year>1998</year><volume>3</volume><fpage>498</fpage><lpage>504</lpage><pub-id pub-id-type="pmid">9657513</pub-id><pub-id pub-id-type="doi">10.1046/j.1365-3156.1998.00250.x</pub-id></citation></ref><ref id="B30"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mutabingwa</surname><given-names>T</given-names></name><name><surname>Anthony</surname><given-names>D</given-names></name><name><surname>Heller</surname><given-names>A</given-names></name><name><surname>Hallett</surname><given-names>R</given-names></name><name><surname>Ahmed</surname><given-names>J</given-names></name><name><surname>Drakeley</surname><given-names>C</given-names></name><name><surname>Greenwood</surname><given-names>BM</given-names></name><name><surname>Whitty</surname><given-names>CJ</given-names></name></person-group><article-title>Amodiaquine alone, amodiaquine + sulfadoxine-pyrimethamine, amodiaquine +artesunate, and artemether-lumefantrine for outpatient treatment of malaria in Tanzanian children: a four-arm randomised effectiveness trial</article-title><source>Lancet</source><year>2005</year><volume>365</volume><fpage>1474</fpage><lpage>1480</lpage><pub-id pub-id-type="pmid">15850631</pub-id><pub-id pub-id-type="doi">10.1016/S0140-6736(05)66417-3</pub-id></citation></ref><ref id="B31"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Checchi</surname><given-names>F</given-names></name><name><surname>Piola</surname><given-names>P</given-names></name><name><surname>Fogg</surname><given-names>P</given-names></name><name><surname>Bajunirwe</surname><given-names>F</given-names></name><name><surname>Biraro</surname><given-names>S</given-names></name><name><surname>Grandesso</surname><given-names>F</given-names></name><name><surname>Ruzagira</surname><given-names>E</given-names></name><name><surname>Babigumira</surname><given-names>J</given-names></name><name><surname>Kigozi</surname><given-names>I</given-names></name><name><surname>Kiguli</surname><given-names>J</given-names></name><name><surname>Kyomuhendo</surname><given-names>J</given-names></name><name><surname>Ferradini</surname><given-names>L</given-names></name><name><surname>Taylor</surname><given-names>WR</given-names></name></person-group><article-title>Supervised versus unsupervised antimalarial treatment with six-dose artemether-lumefantrine: pharmacokinetics and dosage-related findings from a clinical trial in Uganda</article-title><source>Malaria J</source><year>2006</year><volume>5</volume><fpage>59</fpage><pub-id pub-id-type="doi">10.1186/1475-2875-5-59</pub-id></citation></ref><ref id="B32"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kabanywanyi</surname><given-names>AM</given-names></name><name><surname>Mwita</surname><given-names>A</given-names></name><name><surname>Sumari</surname><given-names>D</given-names></name><name><surname>Mandike</surname><given-names>R</given-names></name><name><surname>Mugittu</surname><given-names>K</given-names></name><name><surname>Abdulla</surname><given-names>S</given-names></name></person-group><article-title>Efficacy and safety of artemisinin-based antimalarial in the treatment of uncomplicated malaria in children in southern Tanzania</article-title><source>Malar J</source><year>2007</year><volume>6</volume><fpage>146</fpage><pub-id pub-id-type="pmid">17996121</pub-id><pub-id pub-id-type="doi">10.1186/1475-2875-6-146</pub-id></citation></ref><ref id="B33"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Koram</surname><given-names>KA</given-names></name><name><surname>Abuaku</surname><given-names>B</given-names></name><name><surname>Duah</surname><given-names>N</given-names></name><name><surname>Quashie</surname><given-names>N</given-names></name></person-group><article-title>Comparative efficacy of antimalarial drugs including ACTs in the treatment of uncomplicated malaria among children under 5 years in Ghana</article-title><source>Acta Trop</source><year>2005</year><volume>95</volume><fpage>194</fpage><lpage>203</lpage><pub-id pub-id-type="pmid">16054584</pub-id><pub-id pub-id-type="doi">10.1016/j.actatropica.2005.06.018</pub-id></citation></ref><ref id="B34"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fanello</surname><given-names>CI</given-names></name><name><surname>Karema</surname><given-names>C</given-names></name><name><surname>van Doren</surname><given-names>W</given-names></name><name><surname>Van Overmeir</surname><given-names>C</given-names></name><name><surname>Ngamije</surname><given-names>D</given-names></name><name><surname>D'Alessandro</surname><given-names>U</given-names></name></person-group><article-title>A randomised trial to assess the safety and efficacy of artemether-lumefantrine (Coartem) for the treatment of uncomplicated <italic>Plasmodium falciparum </italic>malaria in Randa</article-title><source>Trans R Soc Trop Med Hyg</source><year>2007</year><volume>101</volume><fpage>344</fpage><lpage>350</lpage><pub-id pub-id-type="pmid">17005222</pub-id><pub-id pub-id-type="doi">10.1016/j.trstmh.2006.06.010</pub-id></citation></ref></ref-list></back></article>


